Last week, World Menopause Day spotlighted a critical issue impacting half the population. The UK government estimated menopause costs the UK economy 14 million working days annually due to women taking time off due to some of the debilitating symptoms. These include hot flushes, insomnia, low mood and/or anxiety, problems

Continue Reading Hot Flush: FemTech Solutions for Women’s Health

Now you’re talking…

If you’ve used one of the recent high-profile AI chatbots, then you’ve no doubt been wowed by their capability. If you haven’t used one, then you’re in an increasingly small population, as these large language models have attracted enormous publicity.

A lot of the publicity has focussed

Continue Reading Life sentence: teaching large language models to read the book of life

On 6 December 2022, the Council of the European Union (“EU Council”) announced that it had adopted a position on its general approach to the development of a harmonised regime for regulating AI in the EU (the proposed EU AI Act (“AI Act”)).

The adoption is

Continue Reading A new approach to regulating AI: EU Council announces adoption of a general approach to the harmonisation of AI regulation

The proposed EU AI Regulation, a comprehensive regime for the purposes of regulating AI in the EU, is set to impact organizations around the world. It is expected that the proposed regulation will be enacted in 2024 or 2025.  Once that happens, those that make AI available within the EU,
Continue Reading Coming EU legislation will change the AI regulatory environment for healthcare technology and life sciences companies

Use of AI in healthcare continues to solidify itself as a solid practice for the benefit of patients and healthcare providers. No more than a cursory search of the subject provides a number of existing examples, such as cancer detection, of AI intervention in AI. In some cases, such
Continue Reading IFPMA issues principles encouraging ethical use of AI in healthcare

By Michal Kasprowicz and Sangeetha Punniyamoorthy

Due to the coronavirus disease 2019 (COVID-19) pandemic there have been recent amendments to Canada’s Patent Act that will authorize the use of certain patented inventions necessary to respond in a public health emergency. These measures will authorize the manufacturing and distribution of patented
Continue Reading COVID-19’s Impact on Canadian patent owners

By Saher Valiani, Matt Holian and Jill Marinoff

Developments in technology are driving major change across all sectors and, in many cases, these changes are significantly impacting legal developments in a particular industry. In the past, pharmaceutical and medical device product liability litigations typically commenced following major regulatory action
Continue Reading An intersection of technology and life sciences: The impact of big data and social media

By Danny Tobey

While artificial intelligence has become the new big thing in medtech, privacy regulations under the Health Insurance Portability and Accountability Act have stayed the same. In this podcast, Medtech Insight interviews Danny Tobey to get a clearer picture of what companies need to know in order to
Continue Reading Podcast: Developing AI tech can mean walking through a patient privacy minefield

Sitting at 36,000 feet over the Atlantic writing this article, I’m unusually aware of the traditional use of the phrase “black box”: an aircraft’s flight data recorder, there to let investigators understand what went awry should the worst happen. It seems odd that a device whose purpose is to provide
Continue Reading Isn’t the whole point of a black box to tell you exactly what happened? AI’s explainability conundrum